Similar and shared nongenomic mechanisms of action of estrogen and thyroid hormone

Faith B. Davis, Hung Yun Lin, Mary K. Luidens, Min Zhou, Shaker A. Mousa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Thyroid hormone and estrogen have nongenomic, as well as genomic, mechanisms of action. Some of these nongenomic actions of thyroid hormone and estrogen are similar or identical. For example, transduction mechanisms of thyroid hormone and estradiol signals at discrete plasma membrane hormone-binding sites of breast cancer cells, but both then utilize activation of mitogen-actrivated protein kinase (MAPK), depend upon MAPK-requiring phosphorylation of serine-118 of the nuclear estrogen receptor (ER)-α and culminate in genomically-directed, ER-dependent breast cancer cell proliferation. In this review, several mechanisms of action of estrogen and thyroid hormone are discussed that are initiated nongenomically, but, downstream of initiation sites are similar or shared. Some of these effects end genomically. The actions include hormone-directed angiogenesis, modulation of activities of plasma membrane ion transporters, regulation of the state of the actin cytoskeleton and stimulation of cancer cell proliferation, including breast and, surprisingly, thyroid cancer.

Original languageEnglish
Pages (from-to)84-89
Number of pages6
JournalImmunology, Endocrine and Metabolic Agents in Medicinal Chemistry
Volume9
Issue number2
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Thyroid Hormones
Estrogens
Mitogens
Estrogen Receptors
Protein Kinases
Cell Proliferation
Cell Membrane
Hormones
Breast Neoplasms
Membrane Transport Proteins
Actin Cytoskeleton
Thyroid Neoplasms
Serine
Estradiol
Breast
Binding Sites
Phosphorylation
Ions
Neoplasms

Keywords

  • Actin
  • Angiogenesis
  • Estradiol
  • Nuclear receptors
  • Thyroxine
  • Triiodothyronine
  • Tumor cell proliferation

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Pharmacology

Cite this

Similar and shared nongenomic mechanisms of action of estrogen and thyroid hormone. / Davis, Faith B.; Lin, Hung Yun; Luidens, Mary K.; Zhou, Min; Mousa, Shaker A.

In: Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 9, No. 2, 2009, p. 84-89.

Research output: Contribution to journalArticle

@article{d96ac5b579744f65aaaa3f9d923421e3,
title = "Similar and shared nongenomic mechanisms of action of estrogen and thyroid hormone",
abstract = "Thyroid hormone and estrogen have nongenomic, as well as genomic, mechanisms of action. Some of these nongenomic actions of thyroid hormone and estrogen are similar or identical. For example, transduction mechanisms of thyroid hormone and estradiol signals at discrete plasma membrane hormone-binding sites of breast cancer cells, but both then utilize activation of mitogen-actrivated protein kinase (MAPK), depend upon MAPK-requiring phosphorylation of serine-118 of the nuclear estrogen receptor (ER)-α and culminate in genomically-directed, ER-dependent breast cancer cell proliferation. In this review, several mechanisms of action of estrogen and thyroid hormone are discussed that are initiated nongenomically, but, downstream of initiation sites are similar or shared. Some of these effects end genomically. The actions include hormone-directed angiogenesis, modulation of activities of plasma membrane ion transporters, regulation of the state of the actin cytoskeleton and stimulation of cancer cell proliferation, including breast and, surprisingly, thyroid cancer.",
keywords = "Actin, Angiogenesis, Estradiol, Nuclear receptors, Thyroxine, Triiodothyronine, Tumor cell proliferation",
author = "Davis, {Faith B.} and Lin, {Hung Yun} and Luidens, {Mary K.} and Min Zhou and Mousa, {Shaker A.}",
year = "2009",
doi = "10.2174/187152209789000696",
language = "English",
volume = "9",
pages = "84--89",
journal = "Anti-Infective Agents in Medicinal Chemistry",
issn = "2211-3525",
publisher = "Bentham Science Publishers",
number = "2",

}

TY - JOUR

T1 - Similar and shared nongenomic mechanisms of action of estrogen and thyroid hormone

AU - Davis, Faith B.

AU - Lin, Hung Yun

AU - Luidens, Mary K.

AU - Zhou, Min

AU - Mousa, Shaker A.

PY - 2009

Y1 - 2009

N2 - Thyroid hormone and estrogen have nongenomic, as well as genomic, mechanisms of action. Some of these nongenomic actions of thyroid hormone and estrogen are similar or identical. For example, transduction mechanisms of thyroid hormone and estradiol signals at discrete plasma membrane hormone-binding sites of breast cancer cells, but both then utilize activation of mitogen-actrivated protein kinase (MAPK), depend upon MAPK-requiring phosphorylation of serine-118 of the nuclear estrogen receptor (ER)-α and culminate in genomically-directed, ER-dependent breast cancer cell proliferation. In this review, several mechanisms of action of estrogen and thyroid hormone are discussed that are initiated nongenomically, but, downstream of initiation sites are similar or shared. Some of these effects end genomically. The actions include hormone-directed angiogenesis, modulation of activities of plasma membrane ion transporters, regulation of the state of the actin cytoskeleton and stimulation of cancer cell proliferation, including breast and, surprisingly, thyroid cancer.

AB - Thyroid hormone and estrogen have nongenomic, as well as genomic, mechanisms of action. Some of these nongenomic actions of thyroid hormone and estrogen are similar or identical. For example, transduction mechanisms of thyroid hormone and estradiol signals at discrete plasma membrane hormone-binding sites of breast cancer cells, but both then utilize activation of mitogen-actrivated protein kinase (MAPK), depend upon MAPK-requiring phosphorylation of serine-118 of the nuclear estrogen receptor (ER)-α and culminate in genomically-directed, ER-dependent breast cancer cell proliferation. In this review, several mechanisms of action of estrogen and thyroid hormone are discussed that are initiated nongenomically, but, downstream of initiation sites are similar or shared. Some of these effects end genomically. The actions include hormone-directed angiogenesis, modulation of activities of plasma membrane ion transporters, regulation of the state of the actin cytoskeleton and stimulation of cancer cell proliferation, including breast and, surprisingly, thyroid cancer.

KW - Actin

KW - Angiogenesis

KW - Estradiol

KW - Nuclear receptors

KW - Thyroxine

KW - Triiodothyronine

KW - Tumor cell proliferation

UR - http://www.scopus.com/inward/record.url?scp=70350028153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350028153&partnerID=8YFLogxK

U2 - 10.2174/187152209789000696

DO - 10.2174/187152209789000696

M3 - Article

AN - SCOPUS:70350028153

VL - 9

SP - 84

EP - 89

JO - Anti-Infective Agents in Medicinal Chemistry

JF - Anti-Infective Agents in Medicinal Chemistry

SN - 2211-3525

IS - 2

ER -